ANI Pharmaceuticals
ANIP
ANIP
121 hedge funds and large institutions have $194M invested in ANI Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less call options, than puts
Call options by funds: $4.58M | Put options by funds: $7.19M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
121
Holding in Top 10
1
Calls
$4.58M
Puts
$7.19M
Top Buyers
| 1 | +$3.41M | |
| 2 | +$2.84M | |
| 3 | +$2.76M | |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$2.52M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.8M |
Top Sellers
| 1 | -$7.74M | |
| 2 | -$7.01M | |
| 3 | -$6.96M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$5.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.81M |